The World Trade Group Scientific Advisory Board is a group of recognized experts and practionners from the life science industry.
The board meets a few times a year, either as a group or on a one-to-one basis to help drive the programmes to ensure it reflects the key industry concerns.
The board continually help review and mould our conference programmes, drawing upon their wealth of experience to advise on current industry developments and potential speakers, with many taking part in the event themselves.
Current Advisory Board Members Include:
Dr. Lee Babiss Head of Global Pharma Research,
Hoffmann-La Roche, Ltd, Switzerland
Dr. David De Graaf Director of Systems Biology
Pfizer Research Technology Center (RTC)USA
Dr. Fadel Hamed Head of Operational Excellence
Genentech Product Operations, USA
Dr. Neil Weir Senior Vice President, Global Research, UCB Celltech UK
Dr. Orest Hurko Assistant Vice President for Clinical Discovery, Translational Research
Wyeth USA
Prof. Ian Wilson Senior Principal Scientist
AstraZeneca UK
Robert Repetto
Director Global New Technology and Innovation, Manufacturing Sciences & Technology, Wyeth Biotech, & Head of Disposables Technologies Task Force, Parenteral Drug Association – PDA USA
Dr. Jinghai J. Xu Director of Automated Biotechnology
Merck & Co USA
Application for membership
We are continually seeking new members to join our advisory boards. If you would like more information or would like to help drive the conference programme by becoming an Advisory Board member, please contact:
Dora Walsh dora.walsh@wtgevents.com
Senior Analyst, Life Science Division, World Trade Group
T: +44 (0) 20 7202 7695
Please note acceptance onto the advisory board is not automatic and each enquiry will be judged on its own merit. The Advisory Board reserves the right to reject applications based on incomplete or unverifiable information.
Home
